A citation-based method for searching scientific literature

Nina Dabelić, Tomislav Jukić, Ana Fröbe. Acta Clin Croat 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hereditary neuroendocrine tumors of the gastroenteropancreatic system.
Martin Anlauf, Nele Garbrecht, Juliane Bauersfeld, Anja Schmitt, Tobias Henopp, Paul Komminoth, Philipp U Heitz, Aurel Perren, Günter Klöppel. Virchows Arch 2007
68
100

The genomic landscape of small intestine neuroendocrine tumors.
Michaela S Banck, Rahul Kanwar, Amit A Kulkarni, Ganesh K Boora, Franziska Metge, Benjamin R Kipp, Lizhi Zhang, Erik C Thorland, Kay T Minn, Ramesh Tentu,[...]. J Clin Invest 2013
195
100

Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus.
Simron Singh, Sylvia L Asa, Chris Dey, Hagen Kennecke, David Laidley, Calvin Law, Timothy Asmis, David Chan, Shereen Ezzat, Rachel Goodwin,[...]. Cancer Treat Rev 2016
52
100

Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study.
Maria Chiara Zatelli, Mirella Torta, Antonette Leon, Maria Rosaria Ambrosio, Massimo Gion, Paola Tomassetti, Filippo De Braud, Gianfranco Delle Fave, Luigi Dogliotti, Ettore C degli Uberti. Endocr Relat Cancer 2007
106
100

Therapeutic sequences in patients with grade 1-2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group.
Antongiulio Faggiano, Silvana Di Maio, Carmela Mocerino, Margaret Ottaviano, Chiara De Divitiis, Valentina Guarnotta, Pasquale Dolce, Roberta Modica, Ivana Puliafito, Lucia Tozzi,[...]. Endocrine 2019
18
100

Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patients.
Wei Sun, Wei Wu, Qifeng Wang, Qian Yao, Qin Feng, Yue Wang, Yu Sun, Yunying Liu, Qian Lai, Gu Zhang,[...]. J Transl Med 2022
1
100

The safety of available treatments options for neuroendocrine tumors.
A Faggiano, F Lo Calzo, G Pizza, R Modica, A Colao. Expert Opin Drug Saf 2017
20
100

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer.
Andreea Newtson, Henry Reyes, Eric J Devor, Michael J Goodheart, Jesus Gonzalez Bosquet. Int J Mol Sci 2021
2
100

Therapeutic Targeting of DNA Damage Response in Cancer.
Wonyoung Choi, Eun Sook Lee. Int J Mol Sci 2022
11
100

The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2 H-pyran-4-yl)-1,3-dihydro-2 H-imidazo[4,5- c]quinolin-2-one).
Kurt G Pike, Bernard Barlaam, Elaine Cadogan, Andrew Campbell, Yingxue Chen, Nicola Colclough, Nichola L Davies, Camila de-Almeida, Sebastien L Degorce, Myriam Didelot,[...]. J Med Chem 2018
59
100

Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades.
Elisabetta Cavalcanti, Vanessa Galleggiante, Sergio Coletta, Elisa Stasi, Marcello Chieppa, Raffaele Armentano, Grazia Serino. Front Oncol 2020
7
100

Circos: an information aesthetic for comparative genomics.
Martin Krzywinski, Jacqueline Schein, Inanç Birol, Joseph Connors, Randy Gascoyne, Doug Horsman, Steven J Jones, Marco A Marra. Genome Res 2009
100

New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors.
Watson P Folk, Alpana Kumari, Tetsushi Iwasaki, Erica K Cassimere, Slovénie Pyndiah, Elizabeth Martin, Kelly Homlar, Daitoku Sakamuro. Int J Mol Sci 2021
1
100

Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches.
Mark Stevenson, Kate E Lines, Rajesh V Thakker. Endocrinol Metab Clin North Am 2018
15
100

The 2019 WHO classification of tumours of the digestive system.
Iris D Nagtegaal, Robert D Odze, David Klimstra, Valerie Paradis, Massimo Rugge, Peter Schirmacher, Kay M Washington, Fatima Carneiro, Ian A Cree. Histopathology 2020
100

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.
Stephen T Durant, Li Zheng, Yingchun Wang, Kan Chen, Lingli Zhang, Tianwei Zhang, Zhenfan Yang, Lucy Riches, Antonio G Trinidad, Jacqueline H L Fok,[...]. Sci Adv 2018
124
100


Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance.
Wei-Yu Chen, Yu-Ching Wen, Shian-Ren Lin, Hsiu-Lien Yeh, Kuo-Ching Jiang, Wei-Hao Chen, Yow-Sien Lin, Qingfu Zhang, Phui-Ly Liew, Michael Hsiao,[...]. Commun Biol 2021
16
100

Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.
Bryan Oronsky, Patrick C Ma, Daniel Morgensztern, Corey A Carter. Neoplasia 2017
292
100

Management of advanced medullary thyroid cancer.
Julien Hadoux, Furio Pacini, R Michael Tuttle, Martin Schlumberger. Lancet Diabetes Endocrinol 2016
65
100

A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial).
Hiroyuki Okuyama, Masafumi Ikeda, Takuji Okusaka, Masayuki Furukawa, Shinichi Ohkawa, Ayumu Hosokawa, Yasushi Kojima, Hiroki Hara, Gou Murohisa, Kazuhiko Shioji,[...]. Neuroendocrinology 2020
13
100

The Role of Serum 5-HIAA as a Predictor of Progression and an Alternative to 24-h Urine 5-HIAA in Well-Differentiated Neuroendocrine Neoplasms.
Maria Wedin, Sagar Mehta, Jenny Angerås-Kraftling, Göran Wallin, Kosmas Daskalakis. Biology (Basel) 2021
8
100

Pathologic Classification of Neuroendocrine Neoplasms.
David S Klimstra. Hematol Oncol Clin North Am 2016
36
100

MDC1 is a mediator of the mammalian DNA damage checkpoint.
Grant S Stewart, Bin Wang, Colin R Bignell, A Malcolm R Taylor, Stephen J Elledge. Nature 2003
665
100

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.
Guido Rindi, David S Klimstra, Behnoush Abedi-Ardekani, Sylvia L Asa, Frederik T Bosman, Elisabeth Brambilla, Klaus J Busam, Ronald R de Krijger, Manfred Dietel, Adel K El-Naggar,[...]. Mod Pathol 2018
464
100

Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis.
Marisa A Bartz-Kurycki, Omowunmi E Oluwo, Lilah F Morris-Wiseman. Ther Adv Endocrinol Metab 2021
3
100

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.
Elisabetta Cavalcanti, Raffaele Armentano, Anna Maria Valentini, Marcello Chieppa, Maria Lucia Caruso. Cell Death Dis 2017
72
100

Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer.
Martina Chiacchiarini, Sofia Trocchianesi, Zein Mersini Besharat, Agnese Po, Elisabetta Ferretti. Pharmacol Ther 2021
5
100

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems.
David S Klimstra, Irvin R Modlin, Domenico Coppola, Ricardo V Lloyd, Saul Suster. Pancreas 2010
728
100


Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma.
Hoda Saghaeiannejad Esfahani, Cory M Vela, Aman Chauhan. Front Oncol 2021
4
100

STAR: ultrafast universal RNA-seq aligner.
Alexander Dobin, Carrie A Davis, Felix Schlesinger, Jorg Drenkow, Chris Zaleski, Sonali Jha, Philippe Batut, Mark Chaisson, Thomas R Gingeras. Bioinformatics 2013
100

Tumor markers in neuroendocrine tumors.
B Eriksson, K Oberg, M Stridsberg. Digestion 2000
190
100

Gastroenteropancreatic Neuroendocrine Tumors.
Mauro Cives, Jonathan R Strosberg. CA Cancer J Clin 2018
235
100

Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma.
C De Divitiis, C von Arx, A M Grimaldi, D Cicala, F Tatangelo, A Arcella, G M Romano, E Simeone, R V Iaffaioli, P A Ascierto,[...]. J Transl Med 2016
11
100

Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC.
Noushin Shabani, Javad Razaviyan, Mahdi Paryan, Seyed Mohammad Tavangar, Fereidoun Azizi, Samira Mohammadi-Yeganeh, Mehdi Hedayati. Hum Pathol 2018
20
100

NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage.
Mitsuru Nakanishi, Toshinori Ozaki, Hideki Yamamoto, Takayuki Hanamoto, Hironobu Kikuchi, Kazushige Furuya, Masahiro Asaka, Domenico Delia, Akira Nakagawara. J Biol Chem 2007
42
100

De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.
Xiwei Wu, George Somlo, Yang Yu, Melanie R Palomares, Arthur Xuejun Li, Weiying Zhou, Amy Chow, Yun Yen, John J Rossi, Harry Gao,[...]. J Transl Med 2012
172
100

Circulating tumor cells as prognostic markers in neuroendocrine tumors.
Mohid S Khan, Amy Kirkwood, Theodora Tsigani, Jorge Garcia-Hernandez, John A Hartley, Martyn E Caplin, Tim Meyer. J Clin Oncol 2013
119
100

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
Joshua M Francis, Adam Kiezun, Alex H Ramos, Stefano Serra, Chandra Sekhar Pedamallu, Zhi Rong Qian, Michaela S Banck, Rahul Kanwar, Amit A Kulkarni, Anna Karpathakis,[...]. Nat Genet 2013
211
100

Maftools: efficient and comprehensive analysis of somatic variants in cancer.
Anand Mayakonda, De-Chen Lin, Yassen Assenov, Christoph Plass, H Phillip Koeffler. Genome Res 2018
100

The UCSC Genome Browser Database: update 2006.
A S Hinrichs, D Karolchik, R Baertsch, G P Barber, G Bejerano, H Clawson, M Diekhans, T S Furey, R A Harte, F Hsu,[...]. Nucleic Acids Res 2006
725
100


One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.
James C Yao, Manal Hassan, Alexandria Phan, Cecile Dagohoy, Colleen Leary, Jeannette E Mares, Eddie K Abdalla, Jason B Fleming, Jean-Nicolas Vauthey, Asif Rashid,[...]. J Clin Oncol 2008
100

The role of Exosomal miRNAs in cancer.
Chuanyun Li, Tong Zhou, Jing Chen, Rong Li, Huan Chen, Shumin Luo, Dexi Chen, Cao Cai, Weihua Li. J Transl Med 2022
12
100

Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients.
Paola Romeo, Carla Colombo, Roberta Granata, Giuseppina Calareso, Ambra Vittoria Gualeni, Matteo Dugo, Loris De Cecco, Maria Grazia Rizzetti, Angela Zanframundo, Antonella Aiello,[...]. Endocr Relat Cancer 2018
35
100

Cytoscape: a software environment for integrated models of biomolecular interaction networks.
Paul Shannon, Andrew Markiel, Owen Ozier, Nitin S Baliga, Jonathan T Wang, Daniel Ramage, Nada Amin, Benno Schwikowski, Trey Ideker. Genome Res 2003
100

mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α.
Hakan Cam, John B Easton, Anthony High, Peter J Houghton. Mol Cell 2010
187
100

iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data.
Riccardo Panero, Antonio Rinaldi, Domenico Memoli, Giovanni Nassa, Maria Ravo, Francesca Rizzo, Roberta Tarallo, Luciano Milanesi, Alessandro Weisz, Giorgio Giurato. Bioinformatics 2017
14
100

Roles for MDC1 in cancer development and treatment.
Sophie E Ruff, Susan K Logan, Michael J Garabedian, Tony T Huang. DNA Repair (Amst) 2020
10
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.